DANGER, a novel protein which physiologically binds to inositol 1,4,5-trisphosphate receptors (IP(3)R). DANGER is a membrane-associated protein predicted to contain a partial MAB-21 domain. It is expressed in a wide variety of neuronal cell lineages where it localizes to membranes in the cell periphery together with IP(3)R. DANGER interacts with IP(3)R in vitro and co-immunoprecipitates with IP(3)R from cellular preparations. DANGER robustly enhances Ca(2+)-mediated inhibition of IP(3) RCa(2+) release without affecting IP(3) binding in microsomal assays and inhibits gating in single-channel recordings of IP(3)R. DANGER appears to allosterically modulate the sensitivity of IP(3) RtoCa(2+) inhibition, which likely alters IP(3)R-mediated Ca(2+) dynamics in cells where DANGER and IP(3)R are co-expressed.
Organism species: Homo sapiens (Human)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Inositol-1,4,5-Triphosphate Receptor Interacting Protein (ITPRIP) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Inositol-1,4,5-Triphosphate Receptor Interacting Protein (ITPRIP) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Inositol-1,4,5-Triphosphate Receptor Interacting Protein (ITPRIP) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Inositol-1,4,5-Triphosphate Receptor Interacting Protein (ITPRIP) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Inositol-1,4,5-Triphosphate Receptor Interacting Protein (ITPRIP) | ELISA Kit Customized Service Offer |
Organism species: Mus musculus (Mouse)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Inositol-1,4,5-Triphosphate Receptor Interacting Protein (ITPRIP) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Inositol-1,4,5-Triphosphate Receptor Interacting Protein (ITPRIP) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Inositol-1,4,5-Triphosphate Receptor Interacting Protein (ITPRIP) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Inositol-1,4,5-Triphosphate Receptor Interacting Protein (ITPRIP) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Inositol-1,4,5-Triphosphate Receptor Interacting Protein (ITPRIP) | ELISA Kit Customized Service Offer |
Organism species: Rattus norvegicus (Rat)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Inositol-1,4,5-Triphosphate Receptor Interacting Protein (ITPRIP) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Inositol-1,4,5-Triphosphate Receptor Interacting Protein (ITPRIP) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Inositol-1,4,5-Triphosphate Receptor Interacting Protein (ITPRIP) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Inositol-1,4,5-Triphosphate Receptor Interacting Protein (ITPRIP) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Inositol-1,4,5-Triphosphate Receptor Interacting Protein (ITPRIP) | ELISA Kit Customized Service Offer |
- "Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro."DNA Res. 7:347-355(2000) [PubMed] [Europe PMC] [Abstract]
- "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
- "The DNA sequence and comparative analysis of human chromosome 10." Nature 429:375-381(2004) [PubMed] [Europe PMC] [Abstract]
- "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
- "DANGER, a novel regulatory protein of inositol 1,4,5-trisphosphate-receptor activity."J. Biol. Chem. 281:37111-37116(2006) [PubMed] [Europe PMC] [Abstract]
- "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]